{"id":"W3154805493","doi":"10.1200/jco.21.00174","title":"Five-Year Outcomes With Pembrolizumab Versus Chemotherapy for Metastatic Non–Small-Cell Lung Cancer With PD-L1 Tumor Proportion Score ≥ 50%","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":1109,"is_retracted":false,"has_abstract":true,"ca_institutions":"Kingston General Hospital","funders":"","keywords":"Pembrolizumab; Medicine; Internal medicine; Chemotherapy; Lung cancer; Hazard ratio; Oncology; Clinical endpoint; Cancer; Surgery; Randomized controlled trial; Immunotherapy; Confidence interval","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001154555,0.0002110467,0.001496945,0.0000862329,0.0000600933,0.00001798482,0.0001294422,0.0001491685,0.0003545884],"category_scores_gemma":[0.0003125173,0.0001213475,0.0005190231,0.0001829194,0.000200943,0.00009930445,0.00001545709,0.000566242,0.000001850256],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002846403,"about_ca_system_score_gemma":0.005502399,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00005049262,"about_ca_topic_score_gemma":0.0003529413,"domain_scores_codex":[0.9974313,0.0001416858,0.001467507,0.0002694699,0.0003938848,0.0002961789],"domain_scores_gemma":[0.9961308,0.0008953079,0.001696175,0.0002236898,0.0008205129,0.0002335382],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.6125771,0.004374218,0.2976188,0.0007353609,0.007841227,0.00205811,0.0004755285,0.00008759458,0.00216627,0.00003174751,0.007818514,0.06421545],"study_design_scores_gemma":[0.278909,0.06574297,0.5732024,0.0009054187,0.004845566,0.001045664,0.001434765,0.00035287,0.003987995,0.00004282724,0.06903633,0.0004942667],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9856274,0.00132414,0.001045129,0.009631712,0.001020289,0.000681775,0.00001087101,0.00001116142,0.0006474874],"genre_scores_gemma":[0.9612191,0.002013221,0.02547897,0.007031133,0.001067011,0.00007821779,0.00001383413,0.00007940272,0.003019142],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3336682,"threshold_uncertainty_score":0.9761019,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08258638092140791,"score_gpt":0.4375760962292222,"score_spread":0.3549897153078143,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}